MARKETSSTORY 1090· JUNE 27, 2026

Decoy Therapeutics Raises Up to $21 Million in Private Placement to Fund Novel Antiviral Platform

Houston biotechnology company Decoy Therapeutics, Inc. (NASDAQ: DCOY) announced on June 26, 2026, that it is raising up to $21 million through a private placement financing. The capital raise centers on advancing the company's Designable…

NDNewsDialy Desk2 MIN READ

SOURCE

prnewswire.com

← PREVIOUS STORY 1089988 LGBTQ+ Crisis Line Set to Relaunch This Year, But the Group That Helped Build It May Be Locked Out NEXT STORY 1091 →BIO 2026 in San Diego Signals a Mood Shift for the Biotech Industry

Keep reading

More from the desk.

35MARKETS

Banks are courting Anthropic employees before a possible IPO

When a company first sells shares to the public, many of its employees become wealthy in a compressed window of time. That event is called an initial public offering, a process by which a private firm becomes publicly traded and employees…

markets2 MIN

348MARKETS

Three Temasek India bets each jump more than 30% after listings this week

A contrarian bet is a position placed against the prevailing market view on an asset, held until that view shifts. Singapore's state investor Temasek made those calls on three companies in India. This week, each of them jumped more than…

markets1 MIN

377MARKETS

Bridgewater trims Amazon as it adds to Shell and PG&E

Big money shifted its holdings last quarter, tilting away from technology and toward energy. Holdings, meaning the shares a fund owns at the end of a reporting period, grew for Shell and PG&E at Bridgewater Associates during the second…

markets1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk